Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00626548
Other study ID # D4320C00015
Secondary ID
Status Terminated
Phase Phase 3
First received January 24, 2008
Last updated August 29, 2012
Start date January 2008
Est. completion date May 2011

Study information

Verified date April 2012
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Enthuse M0 is a large phase III clinical trial studying the efficacy of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC).

This clinical trial will test if the Endothelin A Receptor Antagonist ZD4054 (Zibotentan) can improve progression-free survival and overall survival against a background of existing prostate cancer treatments.

ZD4054 (Zibotentan) is a new type of agent, which is thought to slow tumour growth and spread by blocking Endothelin receptor activity. This trial will look at the effects of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC) patients who have had rising PSA after surgical or medical castration but have no evidence of metastases.

All patients participating in this clinical trial will receive existing prostate cancer treatments in addition to trial therapy.

Half the patients will receive ZD4054 (Zibotentan) , and half the patients will receive placebo in addition to standard prostate cancer therapy. By participating in this trial there is a 50% chance that patients will receive an agent that may slow the progression of the tumour.

No patients will be deprived of standard prostate cancer therapy.


Recruitment information / eligibility

Status Terminated
Enrollment 2577
Est. completion date May 2011
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

Patients who answer TRUE to the following criteria may be eligible to participate in this study.

- Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.

- Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment

- Currently receiving treatment with surgical or medical castration

Exclusion Criteria:

Patients who answer TRUE to the following may NOT be eligible to participate in this study.

- Currently using opiate based pain killers for cancer related pain

- Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial

- Suffering from heart failure or had a myocardial infarction within last 6 months

- A history of epilepsy or seizures

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
ZD4054
10 mg once daily oral dose
Palcebo
Matching Plcebo oral tablet once daily

Locations

Country Name City State
Argentina Research Site Ciudad Autonoma de Buenos Aires Buenos Aires
Argentina Research Site Rosario Santa Fe
Argentina Research Site Santa Fe
Australia Research Site Darlinghurst New South Wales
Australia Research Site Hornsby New South Wales
Australia Research Site Nedlands Western Australia
Australia Research Site Sydney
Australia Research Site Westmead New South Wales
Australia Research Site Wodonga Victoria
Australia Research Site Wollongong New South Wales
Austria Research Site Graz
Austria Research Site Innsbruck
Austria Research Site Wels
Belgium Research Site (Wilrijk) Antwerpen
Belgium Research Site Brussels
Belgium Research Site Edegem
Belgium Research Site Gent
Belgium Research Site Kortrijk
Belgium Research Site Leuven
Belgium Research Site Liege
Brazil Research Site Belo Horizonte Minas Gerais
Brazil Research Site Curitiba Parana
Brazil Research Site Goiania Goias
Brazil Research Site Londrina PR
Brazil Research Site Porto Alegre Rio Grande do Sul
Brazil Research Site Rio de Janeiro RJ
Brazil Research Site Santo Andre Sao Paulo
Brazil Research Site Sao Paulo
Canada Research Site Burlington Ontario
Canada Research Site Calgary Alberta
Canada Research Site Edmonton Alberta
Canada Research Site Greenfeild Park Quebec
Canada Research Site Hamilton Ontario
Canada Research Site Kingston Ontario
Canada Research Site Kitchener Ontario
Canada Research Site London Ontario
Canada Research Site Montreal Quebec
Canada Research Site North York Ontario
Canada Research Site Oakville Ontario
Canada Research Site Point-Claire Quebec
Canada Research Site Quebec City Quebec
Canada Research Site Sherbrooke Quebec
Canada Research Site Toronto Ontario
Canada Research Site Vancouver British Columbia
Canada Research Site Victoria British Columbia
Canada Research Site Winnipeg Manitoba
Chile Research Site La Serena
Chile Research Site Santiago
Chile Research Site Temuco
Chile Research Site Vina del Mar
China Research Site Beijing
China Research Site Chongqing
China Research Site Guangzhou City
China Research Site Hangzhou Zhejiang
China Research Site Hubei
China Research Site Jiangsu
China Research Site Nanjing Jiangsu
China Research Site Shanghai
China Research Site Shanxi
China Research Site Tianjin
China Research Site Zejiang
Colombia Research Site Bogota
Colombia Research Site Medellin
Czech Republic Research Site Brno
Czech Republic Research Site Hradec Kralove
Czech Republic Research Site Jablonec nad Nisou
Czech Republic Research Site Kromeriz
Czech Republic Research Site Olomouc
Czech Republic Research Site Prague 2
Czech Republic Research Site Prague 4
Czech Republic Research Site Prague 6
Czech Republic Research Site Praha
Czech Republic Research Site Usti nad Labem
Denmark Research Site Aalborg
Denmark Research Site Frederiksberg
Denmark Research Site Herlev
Denmark Research Site Holstebro
Denmark Research Site Kobenhavn
Denmark Research Site Odense
Denmark Research Site Roskilde
Finland Research Site Helsinki
Finland Research Site Joensuu
Finland Research Site Oulu
Finland Research Site Seinajoki
Finland Research Site Tampere
France Research Site Caen cedex
France Research Site Creteil
France Research Site Lille
France Research Site Lyon
France Research Site Lyon cedex 03
France Research Site Marseille
France Research Site Montpellier
France Research Site Orleans Cedex
France Research Site Paris
France Research Site Pierre Benite cedex
France Research Site Poitiers Cedex
France Research Site Reims
France Research Site Reims cedex
France Research Site Rennes cedex 9
France Research Site Rouen
France Research Site Suresnes
France Research Site Toulouse
France Research Site Vandoeuvre-les-Nancy cedex
France Research Site Villejuif
Germany Research Site Augsburg
Germany Research Site Bad Ems
Germany Research Site Berlin
Germany Research Site Bonn
Germany Research Site Borken
Germany Research Site Chemnitz
Germany Research Site Emmendingen
Germany Research Site Fuerth
Germany Research Site Gelsenkirchen-Buer
Germany Research Site Germering
Germany Research Site Goettingen
Germany Research Site Holzminden
Germany Research Site Kirchheim/Teck
Germany Research Site Leipzig
Germany Research Site Lubeck
Germany Research Site Mannheim
Germany Research Site Muehlacker
Germany Research Site Muehlheim an der Ruhr
Germany Research Site Muenchen
Germany Research Site Muenchen-Planegg
Germany Research Site Muenster
Germany Research Site Reutlingen
Germany Research Site Rostock
Germany Research Site Tuebingen
Germany Research Site Waltshut-Tiengen
Germany Research Site Wuppertal
Hungary Research Site Budapest
Hungary Research Site Debrecen
Hungary Research Site Gyor
Hungary Research Site Miskolc
Hungary Research Site Nyiregyhaza
Hungary Research Site Szeged
Hungary Research Site Szekesfehervar
India Research Site Ahmedabad Gujarat
India Research Site Chennai Tamil Nadu, India
India Research Site Kochi Kerala
India Research Site Kolkota West Bengal
India Research Site Lucknow Uttar Pradesh
India Research Site Nadiad Gujarat
India Research Site New Delhi
India Research Site Pune Maharashtra
Ireland Research Site Dublin
Ireland Research Site Dublin 7
Ireland Research Site Dublin 8
Israel Research Site Be'er Sheva
Israel Research Site Be'er-Ya'akov
Israel Research Site Haifa
Israel Research Site Holon
Israel Research Site Jeruslaem
Israel Research Site Petah-Tikva
Israel Research Site Tel-HaShomer - Ramat Gan
Italy Research Site Ancona
Italy Research Site Bari
Italy Research Site Bergamo
Italy Research Site Bologna
Italy Research Site Catania
Italy Research Site Como
Italy Research Site Firenze
Italy Research Site Genova
Italy Research Site Messina
Italy Research Site Milano
Italy Research Site Pisa
Italy Research Site Rome
Italy Research Site Terni
Italy Research Site Varese
Japan Research Site Bunkyo-ku Tokyo
Japan Research Site Chiba-City Chiba
Japan Research Site Fuchu_city Tokyo
Japan Research Site Fukuoka-City Fukuoka
Japan Research Site Hamamatsu-city Shizuoka
Japan Research Site Hirosaki-City Aomori
Japan Research Site Ibaraki-machi Ibaraki
Japan Research Site Itabashi-Ku Tokyo
Japan Research Site Kamigyo-ku Kyoto
Japan Research Site Kashihara Nara
Japan Research Site Kita-gun Kagawa
Japan Research Site Kobe-City Hyogo
Japan Research Site Kurashiki Okayama
Japan Research Site Kyoto
Japan Research Site Kyoto-City Kyoto
Japan Research Site Maebashi-City Gunma
Japan Research Site Matsuyama-City Ehime
Japan Research Site Meguro-ku Tokyo
Japan Research Site Minato-Ku Tokyo
Japan Research Site Mitaka-City Tokyo
Japan Research Site Mito-City Ibaraki
Japan Research Site Nagasaki
Japan Research Site Narashino-city Chiba
Japan Research Site Oita-City Oita
Japan Research Site Osaka-City Osaka
Japan Research Site Osaka-Sayama-City Osaka
Japan Research Site Otake-City Hiroshima
Japan Research Site Sagamihara-City Kanagawa
Japan Research Site Sapporo-City Hokkaido
Japan Research Site Sendai-City Miyagi
Japan Research Site Shinjuku-ku Tokyo
Japan Research Site Suita-City Osaka
Japan Research Site Sunto-gun Shizuoka
Japan Research Site Tsukuba-City Ibaraki
Japan Research Site Ueda-City Nagano
Japan Research Site Wako-City Saitama
Korea, Republic of Research Site Bundang-Gu, Seongnam-si Gyeonggi-do
Korea, Republic of Research Site Gangnam-gu Seoul
Korea, Republic of Research Site Seo-gu Pusan
Korea, Republic of Research Site Seodaemun-gu Seoul
Korea, Republic of Research Site Seongbuk-gu Seoul
Korea, Republic of Research Site Songpa-gu Seoul
Latvia Research Site Liepaja
Latvia Research Site Riga
Mexico Research Site Distrito Federal Ciudad de Mexico
Mexico Research Site Mexico DF Distrito Federal
Netherlands Research Site Amsterdam
Netherlands Research Site Arnhem
Netherlands Research Site Eindhoven
Netherlands Research Site Hertogenbosch
Netherlands Research Site Nijmegen
Netherlands Research Site Rotterdam
Netherlands Research Site Tilburg
Norway Research Site Tonsberg
Norway Research Site Trondheim
Peru Research Site Arequipa
Peru Research Site Bellavista
Peru Research Site Jesus Maria
Peru Research Site Lima
Poland Research Site Gdynia
Poland Research Site Kielce
Poland Research Site Koscierzyna
Poland Research Site Szczecin
Poland Research Site Warszawa
Poland Research Site Wroclaw
Portugal Research Site Coimbra
Portugal Research Site Porto
Romania Research Site Bucuresti
Romania Research Site Cluj-Napoca
Romania Research Site Timisoara Timis
Russian Federation Research Site Barnaul
Russian Federation Research Site Izhevsk Russia
Russian Federation Research Site Kursk
Russian Federation Research Site Moscow
Russian Federation Research Site Omsk Omsk region
Russian Federation Research Site Sochi
Russian Federation Research Site St.Petersburg
Russian Federation Research Site Tomsk Tomsk Region
Russian Federation Research Site Voronezh
Serbia Research Site Belgrade
Serbia Research Site Nis
Serbia Research Site Novi Sad
South Africa Research Site Observatory Cape Town
South Africa Research Site Overport Durban
South Africa Research Site Parktown Johannesburg
South Africa Research Site Pietermaritzburg
South Africa Research Site Pretoria
South Africa Research Site Tygerberg Cape Town
Spain Research Site A Corunna
Spain Research Site Barakaldo Bizkaia
Spain Research Site Barcelona
Spain Research Site Bilbao Vizcaya
Spain Research Site Elche Alicante
Spain Research Site Madrid
Spain Research Site Sevilla
Spain Research Site Valencia
Sweden Research Site Gothenburg
Sweden Research Site Helsingborg
Sweden Research Site Jonkoping
Sweden Research Site Orebro
Sweden Research Site Stockholm
Sweden Research Site Uppsala
Switzerland Research Site Aarau
Switzerland Research Site CH-4031 Basel
Switzerland Research Site Locarno
Switzerland Research Site Zuerich
Taiwan Research Site Taipei
Turkey Research Site Ankara
Turkey Research Site Istanbul
Turkey Research Site Izmir
United Kingdom Research Site Cambridge
United Kingdom Research Site Cottingham East Yorkshire
United Kingdom Research Site Coventry
United Kingdom Research Site Glasgow
United Kingdom Research Site Guildford Surrey
United Kingdom Research Site Huddersfield
United Kingdom Research Site Liverpool
United Kingdom Research Site London
United Kingdom Research Site Maidstone Kent
United Kingdom Research Site Manchester
United Kingdom Research Site Newcastle upon Tyne
United Kingdom Research Site Reading Berkshire
United Kingdom Research Site Stevenage Hertfordshire
United States Research Site Atlanta Georgia
United States Research Site Baltimore Maryland
United States Research Site Bismarck North Dakota
United States Research Site Boca Raton Florida
United States Research Site Brooklyn New York
United States Research Site Burlington Vermont
United States Research Site Canton Ohio
United States Research Site Chapel Hill North Carolina
United States Research Site Charleston South Carolina
United States Research Site Cincinnati Ohio
United States Research Site Denver Colorado
United States Research Site Greenbrae California
United States Research Site Kansas City Kansas
United States Research Site Las Vegas Nevada
United States Research Site Lincoln Nebraska
United States Research Site Los Angeles California
United States Research Site Macon Georgia
United States Research Site Memphis Tennessee
United States Research Site Miami Florida
United States Research Site Milwaukee Wisconsin
United States Research Site Minneapolis Minnesota
United States Research Site Mystle Beach South Carolina
United States Research Site Nashville Tennessee
United States Research Site New Orleans Louisiana
United States Research Site Norwich Connecticut
United States Research Site Ocala Florida
United States Research Site Philadelphia Pennsylvania
United States Research Site Pittsburgh Pennsylvania
United States Research Site Port St. Lucie Florida
United States Research Site Raleigh South Carolina
United States Research Site Rockville Maryland
United States Research Site San Antonio Texas
United States Research Site San Diego California
United States Research Site San Francisco California
United States Research Site Seattle Washington
United States Research Site Tucson Arizona
United States Research Site Washington District of Columbia
United States Research Site Wenatchee Washington

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Canada,  Chile,  China,  Colombia,  Czech Republic,  Denmark,  Finland,  France,  Germany,  Hungary,  India,  Ireland,  Israel,  Italy,  Japan,  Korea, Republic of,  Latvia,  Mexico,  Netherlands,  Norway,  Peru,  Poland,  Portugal,  Romania,  Russian Federation,  Serbia,  South Africa,  Spain,  Sweden,  Switzerland,  Taiwan,  Turkey,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Survival Number of participants who have died at early analysis data cut off (DCO) From date of randomization until date of death, assessed up to 33 months No
Primary Progression Free Survival Number of participants who have a progression event at the early analysis DCO, where progression is defined, using RECIST, as a measurable increase in the smallest dimension of any target or non-target lesion, or the appearance of new lesions, since baseline Participants were followed up for progression every 4 weeks for the first 16 weeks then every 16 weeks No
Secondary Health Related Quality of Life Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks No
Secondary Time to Prostate-specific Antigen (PSA) Progression Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks No
Secondary Time to Symptomatic Progression Participants were followed up every 4 weeks for the first 16 weeks then every 16 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A